Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Operating Expenses (2017 - 2025)

Catheter Precision (VTAK) has disclosed Operating Expenses for 9 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 216.06% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 million through Dec 2025, up 88.44% year-over-year, with the annual reading at $21.9 million for FY2025, 88.44% up from the prior year.
  • Operating Expenses for Q4 2025 was $10.1 million at Catheter Precision, up from $3.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $66.6 million in Q1 2023, with the low at $2.7 million in Q1 2024.
  • Average Operating Expenses over 5 years is $8.4 million, with a median of $5.2 million recorded in 2022.
  • The sharpest move saw Operating Expenses skyrocketed 1128.71% in 2023, then plummeted 95.95% in 2024.
  • Over 5 years, Operating Expenses stood at $7.9 million in 2021, then increased by 3.7% to $8.2 million in 2022, then tumbled by 66.91% to $2.7 million in 2023, then increased by 17.33% to $3.2 million in 2024, then skyrocketed by 216.06% to $10.1 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $10.1 million, $3.2 million, and $4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.